Global In-Vitro Diagnostics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • In-Vitro Diagnostics market report explains the definition, types, applications, major countries, and major players of the In-Vitro Diagnostics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Mindray

    • Beckman Coulter Inc

    • Aptiv Solution

    • Bio-Rad Laboratories

    • Becton Dickinson

    • Biomerieux

    • Caprion

    • DAAN Gene

    • Shanghai Kehua Bio-engineering

    • Roche Diagnostics

    • Sysmex Corporation

    • Abbott Laboratories

    • BioSino Bio-technology

    • Siemens Healthcare

    • Ortho Clinical Diagnostics

    • Johnson and Johnson

    • Cobas

    • Merck Millipore

    • Beijing Leadman Biochemistry

    • Danaher Corporation

    • Thermo Scientific

    By Type:

    • Tissue Diagnostics

    • Professional Diagnostics

    • Molecular Diagnostics

    • Diabetes Monitoring

    By End-User:

    • Cancer

    • Infectious Diseases

    • Diabetes

    • Gastrointestinal Disease

    • Autoimmune Diseases

    • Cardiac Disease

    • Drug Testing /Pharmacogenomics

    • HIV/Aids

    • Nephrological Disease

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global In-Vitro Diagnostics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 In-Vitro Diagnostics Outlook to 2028- Original Forecasts

    • 2.2 In-Vitro Diagnostics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term In-Vitro Diagnostics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global In-Vitro Diagnostics Market- Recent Developments

    • 6.1 In-Vitro Diagnostics Market News and Developments

    • 6.2 In-Vitro Diagnostics Market Deals Landscape

    7 In-Vitro Diagnostics Raw Materials and Cost Structure Analysis

    • 7.1 In-Vitro Diagnostics Key Raw Materials

    • 7.2 In-Vitro Diagnostics Price Trend of Key Raw Materials

    • 7.3 In-Vitro Diagnostics Key Suppliers of Raw Materials

    • 7.4 In-Vitro Diagnostics Market Concentration Rate of Raw Materials

    • 7.5 In-Vitro Diagnostics Cost Structure Analysis

      • 7.5.1 In-Vitro Diagnostics Raw Materials Analysis

      • 7.5.2 In-Vitro Diagnostics Labor Cost Analysis

      • 7.5.3 In-Vitro Diagnostics Manufacturing Expenses Analysis

    8 Global In-Vitro Diagnostics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global In-Vitro Diagnostics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global In-Vitro Diagnostics Export by Region (Top 10 Countries) (2017-2028)

    9 Global In-Vitro Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global In-Vitro Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tissue Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Professional Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Molecular Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Diabetes Monitoring Consumption and Growth Rate (2017-2022)

    • 9.2 Global In-Vitro Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Infectious Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Gastrointestinal Disease Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Cardiac Disease Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Drug Testing /Pharmacogenomics Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global HIV/Aids Consumption and Growth Rate (2017-2022)

      • 9.2.9 Global Nephrological Disease Consumption and Growth Rate (2017-2022)

      • 9.2.10 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise In-Vitro Diagnostics Market Analysis and Outlook till 2022

    • 10.1 Global In-Vitro Diagnostics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States In-Vitro Diagnostics Consumption (2017-2022)

      • 10.2.2 Canada In-Vitro Diagnostics Consumption (2017-2022)

      • 10.2.3 Mexico In-Vitro Diagnostics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.2 UK In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.3 Spain In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.4 Belgium In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.5 France In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.6 Italy In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.7 Denmark In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.8 Finland In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.9 Norway In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.10 Sweden In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.11 Poland In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.12 Russia In-Vitro Diagnostics Consumption (2017-2022)

      • 10.3.13 Turkey In-Vitro Diagnostics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.2 Japan In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.3 India In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.4 South Korea In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.5 Pakistan In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.6 Bangladesh In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.7 Indonesia In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.8 Thailand In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.9 Singapore In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.10 Malaysia In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.11 Philippines In-Vitro Diagnostics Consumption (2017-2022)

      • 10.4.12 Vietnam In-Vitro Diagnostics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil In-Vitro Diagnostics Consumption (2017-2022)

      • 10.5.2 Colombia In-Vitro Diagnostics Consumption (2017-2022)

      • 10.5.3 Chile In-Vitro Diagnostics Consumption (2017-2022)

      • 10.5.4 Argentina In-Vitro Diagnostics Consumption (2017-2022)

      • 10.5.5 Venezuela In-Vitro Diagnostics Consumption (2017-2022)

      • 10.5.6 Peru In-Vitro Diagnostics Consumption (2017-2022)

      • 10.5.7 Puerto Rico In-Vitro Diagnostics Consumption (2017-2022)

      • 10.5.8 Ecuador In-Vitro Diagnostics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain In-Vitro Diagnostics Consumption (2017-2022)

      • 10.6.2 Kuwait In-Vitro Diagnostics Consumption (2017-2022)

      • 10.6.3 Oman In-Vitro Diagnostics Consumption (2017-2022)

      • 10.6.4 Qatar In-Vitro Diagnostics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia In-Vitro Diagnostics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates In-Vitro Diagnostics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria In-Vitro Diagnostics Consumption (2017-2022)

      • 10.7.2 South Africa In-Vitro Diagnostics Consumption (2017-2022)

      • 10.7.3 Egypt In-Vitro Diagnostics Consumption (2017-2022)

      • 10.7.4 Algeria In-Vitro Diagnostics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia In-Vitro Diagnostics Consumption (2017-2022)

      • 10.8.2 New Zealand In-Vitro Diagnostics Consumption (2017-2022)

    11 Global In-Vitro Diagnostics Competitive Analysis

    • 11.1 Mindray

      • 11.1.1 Mindray Company Details

      • 11.1.2 Mindray In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Mindray In-Vitro Diagnostics Main Business and Markets Served

      • 11.1.4 Mindray In-Vitro Diagnostics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Beckman Coulter Inc

      • 11.2.1 Beckman Coulter Inc Company Details

      • 11.2.2 Beckman Coulter Inc In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Beckman Coulter Inc In-Vitro Diagnostics Main Business and Markets Served

      • 11.2.4 Beckman Coulter Inc In-Vitro Diagnostics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Aptiv Solution

      • 11.3.1 Aptiv Solution Company Details

      • 11.3.2 Aptiv Solution In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Aptiv Solution In-Vitro Diagnostics Main Business and Markets Served

      • 11.3.4 Aptiv Solution In-Vitro Diagnostics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Bio-Rad Laboratories

      • 11.4.1 Bio-Rad Laboratories Company Details

      • 11.4.2 Bio-Rad Laboratories In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Bio-Rad Laboratories In-Vitro Diagnostics Main Business and Markets Served

      • 11.4.4 Bio-Rad Laboratories In-Vitro Diagnostics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Becton Dickinson

      • 11.5.1 Becton Dickinson Company Details

      • 11.5.2 Becton Dickinson In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Becton Dickinson In-Vitro Diagnostics Main Business and Markets Served

      • 11.5.4 Becton Dickinson In-Vitro Diagnostics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Biomerieux

      • 11.6.1 Biomerieux Company Details

      • 11.6.2 Biomerieux In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Biomerieux In-Vitro Diagnostics Main Business and Markets Served

      • 11.6.4 Biomerieux In-Vitro Diagnostics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Caprion

      • 11.7.1 Caprion Company Details

      • 11.7.2 Caprion In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Caprion In-Vitro Diagnostics Main Business and Markets Served

      • 11.7.4 Caprion In-Vitro Diagnostics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 DAAN Gene

      • 11.8.1 DAAN Gene Company Details

      • 11.8.2 DAAN Gene In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 DAAN Gene In-Vitro Diagnostics Main Business and Markets Served

      • 11.8.4 DAAN Gene In-Vitro Diagnostics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Shanghai Kehua Bio-engineering

      • 11.9.1 Shanghai Kehua Bio-engineering Company Details

      • 11.9.2 Shanghai Kehua Bio-engineering In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Shanghai Kehua Bio-engineering In-Vitro Diagnostics Main Business and Markets Served

      • 11.9.4 Shanghai Kehua Bio-engineering In-Vitro Diagnostics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Roche Diagnostics

      • 11.10.1 Roche Diagnostics Company Details

      • 11.10.2 Roche Diagnostics In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Roche Diagnostics In-Vitro Diagnostics Main Business and Markets Served

      • 11.10.4 Roche Diagnostics In-Vitro Diagnostics Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Sysmex Corporation

      • 11.11.1 Sysmex Corporation Company Details

      • 11.11.2 Sysmex Corporation In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Sysmex Corporation In-Vitro Diagnostics Main Business and Markets Served

      • 11.11.4 Sysmex Corporation In-Vitro Diagnostics Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Abbott Laboratories

      • 11.12.1 Abbott Laboratories Company Details

      • 11.12.2 Abbott Laboratories In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Abbott Laboratories In-Vitro Diagnostics Main Business and Markets Served

      • 11.12.4 Abbott Laboratories In-Vitro Diagnostics Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 BioSino Bio-technology

      • 11.13.1 BioSino Bio-technology Company Details

      • 11.13.2 BioSino Bio-technology In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 BioSino Bio-technology In-Vitro Diagnostics Main Business and Markets Served

      • 11.13.4 BioSino Bio-technology In-Vitro Diagnostics Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Siemens Healthcare

      • 11.14.1 Siemens Healthcare Company Details

      • 11.14.2 Siemens Healthcare In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Siemens Healthcare In-Vitro Diagnostics Main Business and Markets Served

      • 11.14.4 Siemens Healthcare In-Vitro Diagnostics Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Ortho Clinical Diagnostics

      • 11.15.1 Ortho Clinical Diagnostics Company Details

      • 11.15.2 Ortho Clinical Diagnostics In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Main Business and Markets Served

      • 11.15.4 Ortho Clinical Diagnostics In-Vitro Diagnostics Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Johnson and Johnson

      • 11.16.1 Johnson and Johnson Company Details

      • 11.16.2 Johnson and Johnson In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Johnson and Johnson In-Vitro Diagnostics Main Business and Markets Served

      • 11.16.4 Johnson and Johnson In-Vitro Diagnostics Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Cobas

      • 11.17.1 Cobas Company Details

      • 11.17.2 Cobas In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Cobas In-Vitro Diagnostics Main Business and Markets Served

      • 11.17.4 Cobas In-Vitro Diagnostics Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Merck Millipore

      • 11.18.1 Merck Millipore Company Details

      • 11.18.2 Merck Millipore In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Merck Millipore In-Vitro Diagnostics Main Business and Markets Served

      • 11.18.4 Merck Millipore In-Vitro Diagnostics Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Beijing Leadman Biochemistry

      • 11.19.1 Beijing Leadman Biochemistry Company Details

      • 11.19.2 Beijing Leadman Biochemistry In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Beijing Leadman Biochemistry In-Vitro Diagnostics Main Business and Markets Served

      • 11.19.4 Beijing Leadman Biochemistry In-Vitro Diagnostics Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Danaher Corporation

      • 11.20.1 Danaher Corporation Company Details

      • 11.20.2 Danaher Corporation In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Danaher Corporation In-Vitro Diagnostics Main Business and Markets Served

      • 11.20.4 Danaher Corporation In-Vitro Diagnostics Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    • 11.21 Thermo Scientific

      • 11.21.1 Thermo Scientific Company Details

      • 11.21.2 Thermo Scientific In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.21.3 Thermo Scientific In-Vitro Diagnostics Main Business and Markets Served

      • 11.21.4 Thermo Scientific In-Vitro Diagnostics Product Portfolio

      • 11.21.5 Recent Research and Development Strategies

    12 Global In-Vitro Diagnostics Market Outlook by Types and Applications to 2028

    • 12.1 Global In-Vitro Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Tissue Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Professional Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Diabetes Monitoring Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global In-Vitro Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Gastrointestinal Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Cardiac Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Drug Testing /Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.8 Global HIV/Aids Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.9 Global Nephrological Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.10 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise In-Vitro Diagnostics Market Analysis and Outlook to 2028

    • 13.1 Global In-Vitro Diagnostics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.2.2 Canada In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico In-Vitro Diagnostics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.2 UK In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.3 Spain In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.5 France In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.6 Italy In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.8 Finland In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.9 Norway In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.11 Poland In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.12 Russia In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey In-Vitro Diagnostics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.2 Japan In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.3 India In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam In-Vitro Diagnostics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.5.3 Chile In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.5.6 Peru In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador In-Vitro Diagnostics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.6.3 Oman In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates In-Vitro Diagnostics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria In-Vitro Diagnostics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia In-Vitro Diagnostics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand In-Vitro Diagnostics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of In-Vitro Diagnostics

    • Figure of In-Vitro Diagnostics Picture

    • Table Global In-Vitro Diagnostics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global In-Vitro Diagnostics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Tissue Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Professional Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Molecular Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Monitoring Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiac Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Testing /Pharmacogenomics Consumption and Growth Rate (2017-2022)

    • Figure Global HIV/Aids Consumption and Growth Rate (2017-2022)

    • Figure Global Nephrological Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global In-Vitro Diagnostics Consumption by Country (2017-2022)

    • Table North America In-Vitro Diagnostics Consumption by Country (2017-2022)

    • Figure United States In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Canada In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Mexico In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe In-Vitro Diagnostics Consumption by Country (2017-2022)

    • Figure Germany In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure UK In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Spain In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Belgium In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure France In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Italy In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Denmark In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Finland In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Norway In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Sweden In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Poland In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Russia In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Turkey In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Table APAC In-Vitro Diagnostics Consumption by Country (2017-2022)

    • Figure China In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Thailand In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Singapore In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Philippines In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Table South America In-Vitro Diagnostics Consumption by Country (2017-2022)

    • Figure Brazil In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Colombia In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Chile In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Argentina In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Peru In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Table GCC In-Vitro Diagnostics Consumption by Country (2017-2022)

    • Figure Bahrain In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Oman In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Qatar In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Africa In-Vitro Diagnostics Consumption by Country (2017-2022)

    • Figure Nigeria In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Africa In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Egypt In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Algeria In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Oceania In-Vitro Diagnostics Consumption by Country (2017-2022)

    • Figure Australia In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Mindray Company Details

    • Table Mindray In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mindray In-Vitro Diagnostics Main Business and Markets Served

    • Table Mindray In-Vitro Diagnostics Product Portfolio

    • Table Beckman Coulter Inc Company Details

    • Table Beckman Coulter Inc In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckman Coulter Inc In-Vitro Diagnostics Main Business and Markets Served

    • Table Beckman Coulter Inc In-Vitro Diagnostics Product Portfolio

    • Table Aptiv Solution Company Details

    • Table Aptiv Solution In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aptiv Solution In-Vitro Diagnostics Main Business and Markets Served

    • Table Aptiv Solution In-Vitro Diagnostics Product Portfolio

    • Table Bio-Rad Laboratories Company Details

    • Table Bio-Rad Laboratories In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories In-Vitro Diagnostics Main Business and Markets Served

    • Table Bio-Rad Laboratories In-Vitro Diagnostics Product Portfolio

    • Table Becton Dickinson Company Details

    • Table Becton Dickinson In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson In-Vitro Diagnostics Main Business and Markets Served

    • Table Becton Dickinson In-Vitro Diagnostics Product Portfolio

    • Table Biomerieux Company Details

    • Table Biomerieux In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biomerieux In-Vitro Diagnostics Main Business and Markets Served

    • Table Biomerieux In-Vitro Diagnostics Product Portfolio

    • Table Caprion Company Details

    • Table Caprion In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Caprion In-Vitro Diagnostics Main Business and Markets Served

    • Table Caprion In-Vitro Diagnostics Product Portfolio

    • Table DAAN Gene Company Details

    • Table DAAN Gene In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table DAAN Gene In-Vitro Diagnostics Main Business and Markets Served

    • Table DAAN Gene In-Vitro Diagnostics Product Portfolio

    • Table Shanghai Kehua Bio-engineering Company Details

    • Table Shanghai Kehua Bio-engineering In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Kehua Bio-engineering In-Vitro Diagnostics Main Business and Markets Served

    • Table Shanghai Kehua Bio-engineering In-Vitro Diagnostics Product Portfolio

    • Table Roche Diagnostics Company Details

    • Table Roche Diagnostics In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics In-Vitro Diagnostics Main Business and Markets Served

    • Table Roche Diagnostics In-Vitro Diagnostics Product Portfolio

    • Table Sysmex Corporation Company Details

    • Table Sysmex Corporation In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sysmex Corporation In-Vitro Diagnostics Main Business and Markets Served

    • Table Sysmex Corporation In-Vitro Diagnostics Product Portfolio

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories In-Vitro Diagnostics Main Business and Markets Served

    • Table Abbott Laboratories In-Vitro Diagnostics Product Portfolio

    • Table BioSino Bio-technology Company Details

    • Table BioSino Bio-technology In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioSino Bio-technology In-Vitro Diagnostics Main Business and Markets Served

    • Table BioSino Bio-technology In-Vitro Diagnostics Product Portfolio

    • Table Siemens Healthcare Company Details

    • Table Siemens Healthcare In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare In-Vitro Diagnostics Main Business and Markets Served

    • Table Siemens Healthcare In-Vitro Diagnostics Product Portfolio

    • Table Ortho Clinical Diagnostics Company Details

    • Table Ortho Clinical Diagnostics In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ortho Clinical Diagnostics In-Vitro Diagnostics Main Business and Markets Served

    • Table Ortho Clinical Diagnostics In-Vitro Diagnostics Product Portfolio

    • Table Johnson and Johnson Company Details

    • Table Johnson and Johnson In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson In-Vitro Diagnostics Main Business and Markets Served

    • Table Johnson and Johnson In-Vitro Diagnostics Product Portfolio

    • Table Cobas Company Details

    • Table Cobas In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cobas In-Vitro Diagnostics Main Business and Markets Served

    • Table Cobas In-Vitro Diagnostics Product Portfolio

    • Table Merck Millipore Company Details

    • Table Merck Millipore In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Millipore In-Vitro Diagnostics Main Business and Markets Served

    • Table Merck Millipore In-Vitro Diagnostics Product Portfolio

    • Table Beijing Leadman Biochemistry Company Details

    • Table Beijing Leadman Biochemistry In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Leadman Biochemistry In-Vitro Diagnostics Main Business and Markets Served

    • Table Beijing Leadman Biochemistry In-Vitro Diagnostics Product Portfolio

    • Table Danaher Corporation Company Details

    • Table Danaher Corporation In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Corporation In-Vitro Diagnostics Main Business and Markets Served

    • Table Danaher Corporation In-Vitro Diagnostics Product Portfolio

    • Table Thermo Scientific Company Details

    • Table Thermo Scientific In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Scientific In-Vitro Diagnostics Main Business and Markets Served

    • Table Thermo Scientific In-Vitro Diagnostics Product Portfolio

    • Figure Global Tissue Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Professional Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Monitoring Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiac Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Testing /Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HIV/Aids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nephrological Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)

    • Table North America In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Germany In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure China In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Brazil In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Australia In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.